Additionally, anti‐angiogenic therapy has been found to normalize disorganized tumor blood vessels and reduce the recruitment of immune‐inhibitory factors such as IL‐6, IL‐10, and indoleamine 2,3‐dioxygenase (IDO), improving the efficacy of immunotherapy [63]. This evidence concerns the gene IDO1 and neoplasm.